Financial News
Latest News about CYBN
Recent news which mentions CYBN
Seelos Therapeutics, Allied Among Top Psychedelic Movers Of Today
September 20, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From September 19, 2022
September 19, 2022
From Benzinga
Numinus Wellness, GH Research Among Top Psychedelic Movers Of Today
September 15, 2022
From Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
September 14, 2022
From Benzinga
Biomind Labs, Allied Among Top Psychedelic Movers Of Today
September 12, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From September 9, 2022
September 09, 2022
From Benzinga
Small Pharma, Seelos Therapeutics Among Top Psychedelic Movers Of Today
September 08, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From September 7, 2022
September 07, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From September 6, 2022
September 06, 2022
From Benzinga
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
September 02, 2022
From Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
September 01, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From August 31, 2022
August 31, 2022
From Benzinga
Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression
August 30, 2022
Tickers
CYBN
From Benzinga
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
August 30, 2022
From Benzinga
From Benzinga
7 Psychedelics Stocks to Buy for a Big Drug Boom
August 30, 2022
From InvestorPlace
Small Pharma, Biomind Labs Among Top Psychedelic Movers Of Today
August 29, 2022
From Benzinga
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From August 23, 2022
August 23, 2022
From Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
August 22, 2022
From Benzinga
From Benzinga
Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session
August 19, 2022
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From August 17, 2022
August 17, 2022
From Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
August 17, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From August 16, 2022
August 16, 2022
From Benzinga
These Depression Players Are Top Picks For $400B Mental Healthcare Market, Says Analyst
August 16, 2022
From Benzinga
Allied, Cybin Among Top Psychedelic Movers Of Today
August 15, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
